Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

August 29, 2022

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2027

Conditions
Spine Metastases
Interventions
RADIATION

Prophylactic Radiotherapy

Radiation therapy will be delivered according to department standards. For this protocol, total dose and dose fractionation may be delivered at the discretion of the treating radiation oncologist according to department standards. All techniques including conventional, three-dimensional conformal radiation therapy (3D-CRT), intensity-modulated radiation therapy (IMRT), and stereotactic radiosurgery/stereotactic body radiation therapy (SRS/SBRT) techniques may be used. Image guidance at the time of treatment delivery to verify patient positioning may be chosen at the discretion of the treating radiation oncologist according to department standards.

DRUG

Standard of care systemic therapy

Standard of care systemic therapy, including chemotherapeutics, targeted therapies, immunomodulatory agents, and hormonal therapies will be delivered at the discretion of the treating medical oncologist. Patients may receive systemic therapy concurrently and there are no restrictions on initiation of systemic agents after radiotherapy including immunotherapy and hormonal therapy, the timing of which will be determined by a consensus between the treating medical and radiation oncologists.

Trial Locations (1)

33176

RECRUITING

Miami Cancer Institute at Baptist Health South Florida, Miami

All Listed Sponsors
lead

Baptist Health South Florida

OTHER